Aurdan Capital Management’s Medtronic MDT Stock Holding History

Aurdan Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,042	Closed	-$783K	–	101
2026 Q1	$783K	Sell	9,042 -1,887	-17%	-$181K	0.24%	52
2025 Q4	$1.05M	Sell	10,929 -806	-7%	-$78.3K	0.32%	43
2025 Q3	$1.12M	Sell	11,735 -11,655	-50%	-$1.07M	0.36%	44
2025 Q2	$2.04M	Sell	23,390 -1,130	-5%	-$95.8K	0.69%	36
2025 Q1	$2.2M	Sell	24,520 -15,812	-39%	-$1.41M	0.83%	33
2024 Q4	$3.22M	Buy	+40,332	New	+$3.49M	1.24%	26

Other funds holding MDT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Aurdan Capital Management's MDT Position: Q2 2026 in Review

Aurdan Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 9,042 shares — an estimated $783K sold.

Aurdan Capital Management first reported a position in MDT in Q4 2024 and held it in 6 quarters. The position peaked at $3.22M in Q4 2024. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Aurdan Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Aurdan Capital Management sold 9,042 Medtronic shares in Q2 2026, an estimated $783K.
Aurdan Capital Management first reported a position in Medtronic in Q4 2024 and held it in 6 quarters.
Aurdan Capital Management's Medtronic position peaked at $3.22M in Q4 2024.
961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.